| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +33.33% | +6.32% | +0.75% | +5.57% | -0.06% | — |
| 14d | 6 | +50.00% | +5.31% | +1.61% | +3.70% | +3.67% | — |
| 30d | 6 | +66.67% | +10.42% | +3.22% | +7.20% | -0.19% | — |
| 60d | 6 | +50.00% | -18.92% | +4.39% | -23.31% | -28.40% | — |
| 90d | 6 | +50.00% | -2.31% | +4.97% | -7.28% | -5.42% | — |
| 180d | 6 | +50.00% | -35.78% | +7.53% | -43.32% | -61.58% | — |
| 1y | 6 | +66.67% | -51.71% | +20.45% | -72.16% | -86.54% | — |
| 2y | 6(4 pending) | +50.00% | -83.97% | +53.29% | -137.26% | -137.26% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| XFOR X4 PHARMACEUTICALS, INC | PURCHASE Chief Commercial Officer | 1,032 | $2.48 | $2.6K | 25,337 | May 16, 2025 | May 20, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 1,032 | $2.48 | $2.6K | 25,337 | May 16, 2025 | Jun 3, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 600,000 | — | — | 729,173 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Commercial Officer | 29,159 | $0.45 | $13.2K | 94,123 | Jan 24, 2025 | Jan 27, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 74,773 | — | — | 123,282 | Jan 23, 2025 | Jan 27, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASE Chief Commercial Officer | 13,404 | $0.34 | $4.6K | 129,173 | Nov 15, 2024 | Feb 14, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Commercial Officer | 11,127 | $0.58 | $6.5K | 48,509 | Oct 7, 2024 | Oct 8, 2024 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 34,946 | — | — | 59,636 | Oct 4, 2024 | Oct 8, 2024 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASE Chief Commercial Officer | 21,646 | $0.68 | $14.7K | 115,769 | May 17, 2024 | Feb 14, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 523,414 | — | — | 523,414 | Feb 13, 2024 | Feb 16, 2024 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE10b5-1 10b5-1 plan | 10,257 | $0.73 | $7.5K | 24,690 | Nov 1, 2023 | Nov 3, 2023 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 34,947 | — | — | 34,947 | Oct 31, 2023 | Nov 2, 2023 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 341,000 | $1.89 | $644.5K | 341,000 | Nov 3, 2022 | Nov 4, 2022 ↗ | View → |